Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Predictive Individual Effect for Survival Data.
Neuenschwander B, Roychoudhury S, Wandel S, Natarajan K, Zuber E. Neuenschwander B, et al. Among authors: zuber e. Ther Innov Regul Sci. 2022 May;56(3):492-500. doi: 10.1007/s43441-022-00386-0. Epub 2022 Mar 16. Ther Innov Regul Sci. 2022. PMID: 35294767
A proof of concept phase II non-inferiority criterion.
Neuenschwander B, Rouyrre N, Hollaender N, Zuber E, Branson M. Neuenschwander B, et al. Among authors: zuber e. Stat Med. 2011 Jun 15;30(13):1618-27. doi: 10.1002/sim.3997. Epub 2011 Feb 24. Stat Med. 2011. PMID: 21351286
Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study.
Pozzo C, Barone C, Szanto J, Padi E, Peschel C, Bükki J, Gorbunova V, Valvere V, Zaluski J, Biakhov M, Zuber E, Jacques C, Bugat R. Pozzo C, et al. Among authors: zuber e. Ann Oncol. 2004 Dec;15(12):1773-81. doi: 10.1093/annonc/mdh473. Ann Oncol. 2004. PMID: 15550582 Free article. Clinical Trial.
Methodology for Good Machine Learning with Multi-Omics Data.
Coroller T, Sahiner B, Amatya A, Gossmann A, Karagiannis K, Moloney C, Samala RK, Santana-Quintero L, Solovieff N, Wang C, Amiri-Kordestani L, Cao Q, Cha KH, Charlab R, Cross FH Jr, Hu T, Huang R, Kraft J, Krusche P, Li Y, Li Z, Mazo I, Paul R, Schnakenberg S, Serra P, Smith S, Song C, Su F, Tiwari M, Vechery C, Xiong X, Zarate JP, Zhu H, Chakravartty A, Liu Q, Ohlssen D, Petrick N, Schneider JA, Walderhaug M, Zuber E. Coroller T, et al. Among authors: zuber e. Clin Pharmacol Ther. 2024 Apr;115(4):745-757. doi: 10.1002/cpt.3105. Epub 2024 Jan 31. Clin Pharmacol Ther. 2024. PMID: 37965805
Stem Cells in Ovarian Cancer and Potential Therapies.
Zuber E, Schweitzer D, Allen D, Parte S, Kakar SS. Zuber E, et al. Proc Stem Cell Res Oncog. 2020 May;8:e1001. Epub 2020 May 3. Proc Stem Cell Res Oncog. 2020. PMID: 32776013 Free PMC article. No abstract available.
58 results